The present disclosure relates to a method of preventing and/or treating non-alcoholic steatohepatitis in a subject in need thereof, comprising administering to the subject a pharmaceutically effective amount of a compound of Formula (II):wherein R1, R2, R3, X and Y are as defined in the specification；or a pharmaceutically acceptable salt, solvate, or solvate of such a salt.More particularly, the present disclosure relates to a method of preventing and/or treating non-alcoholic steatohepatitis in a subject in need thereof, comprising administering to the subject a pharmaceutically effective amount of a compound of Formula (I):wherein R2, R3, and X, are as defined in the specification；or a pharmaceutically acceptable salt, solvate, or solvate of such a salt.Further, the present invention relates to a compound of Formula (I) for preventing and/or treating non-alcoholic steatohepatitis, wherein R2, R3 and X are as defined in the specification； or a pharmaceutically acceptable salt, solvate, or solvate of such a salt.
